Related Experiment Video
Updated: May 26, 2026
07:39
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Mechanical circulatory support for right heart failure: current technology and future outlook
Po-Lin Hsu1, Jack Parker, Christina Egger
1Department of Cardiovascular Engineering Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University, Germany. hsu@hia.rwth-aachen.de
Artificial Organs
|December 14, 2011
Summary
Right heart failure is a significant concern after cardiac surgery, especially with left ventricular assist devices (LVADs). This review covers current and emerging right ventricular assist devices (RVADs) to improve patient outcomes.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Devices
Background:
- Congestive heart failure prevalence is rising globally, posing a significant healthcare challenge.
- Isolated right heart dysfunction post-cardiotomy carries a poor prognosis and high mortality.
- Right heart failure affects over 40% of patients receiving left ventricular assist devices (LVADs) or cardiac transplantation.
Purpose of the Study:
- To review the current state of right ventricular assist device (RVAD) technology.
- To categorize existing and developing RVADs.
- To discuss future considerations for RVAD development.
Main Methods:
- Literature review of clinical and developmental RVADs.
- Categorization of RVADs based on technology and application.
- Analysis of current RV assistance status and future outlook.
Main Results:
- Mechanical cardiac assistance via VADs is established for end-stage heart failure.
- Right ventricular assist device (RVAD) technology is less developed than LVADs.
- Reviewed devices include extracorporeal, percutaneous, and implantable RVADs, with emerging technologies also discussed.
Conclusions:
- RVAD technology is evolving, with various devices in clinical use and development.
- Further advancements are needed to improve outcomes for patients with right heart failure.
- Successful future RVAD development requires careful consideration of technological and clinical factors.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...